LiveAstraZeneca Covid-19 Vaccine Shows 76% Efficacy
After getting a red flag on its US trial from the independent data safety monitoring board (DSMB), AstraZeneca plc on Thursday announced results based on...
Category : WORLD
AstraZeneca COVID-19 Vaccine 76 Per Cent Effective in Updated US Trail
AstraZeneca said its COVID-19 vaccine was 76 per cent effective at preventing symptomatic illness in a new analysis of its major US trial a tad...
Netanyahu Urges Rival to Join Unity Government
After claiming a ‘giant victory’ in the parliamentary election, Israel Prime Minister Benjamin Netanyahu on Wednesday pleaded with members of rival parties to put aside...
Tesla’s In-Car Cameras Raise Privacy Concerns
Tesla‘s use of in-car cameras to record and transmit video footage of passengers to develop self-driving technology raises privacy concerns, influential U.S. magazine Consumer Reports...
Prince Harry Joins Coaching Startup BetterUp As CIO
Prince Harry has joined the corporate world as employee coaching and mental health firm BetterUp Inc.’s Chief Impact Officer. The financial terms of his employment...
Blinken Offers Boost for NATO, Cooperation on Afghanistan
US Secretary of State Antony Blinken on Tuesday pledged to rebuild and revitalize the transatlantic NATO military alliance and to share American plans on any...
Twitter CEO Dorsey Sells NFT of First Tweet for $2.9 Million
Twitter CEO Jack Dorsey has sold a digital version of his first tweet for more than USD 2.9 million more than two weeks after he...
AstraZeneca Covid 19 Vaccine Shows 79% Efficacy in US Phase 3 Trial
AstraZeneca plc’s covid-19 vaccine, the company said that the jab showed an efficacy of 79 per cent in phase 3 trials in the US, Chile...
Dozens of Towns Isolated by Flooding in Australian State
Hundreds of people have been rescued from floodwaters that have isolated dozens of towns in Australia‘s most populous state New South Wales and forced thousands...
Ocugen Seeks to Sell 100 Mn Bharat Biotech’s Covaxin Doses in US in 2021
Ocugen Inc seeks to sell 100 million doses of India’s state-backed COVID-19 vaccine COVAXIN in the United States this year, the U.S. firm’s chief executive...